Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares, requiring an investment of ₹14,820 at the upper price band..
Syndicated via official news feed
Syndicated feed content with full publisher credit.
Continue reading verified coverage and related developments on this desk.
Latest developments and reports from the desk
Country’s solar push highlights momentum — and obstacles — around green energy shift
Gaja Alternative's share price dropped more than 8% after a strong debut at a premium of around 16%. Despite this correction, it remained over 6% above its IPO price. Analysts suggest a cautious approach to investment…
Wall Street’s Best Oil Stock of 2026 Isn’t Who You Think